Kepler Capital Markets set a €119.00 ($141.67) price objective on Merck KGaA (FRA:MRK) in a research report sent to investors on Thursday morning. The brokerage currently has a buy rating on the healthcare company’s stock.

Several other analysts also recently weighed in on MRK. Goldman Sachs Group, Inc. (The) set a €105.00 ($125.00) price objective on Merck KGaA and gave the company a neutral rating in a research report on Tuesday. Deutsche Bank AG set a €106.00 ($126.19) price objective on Merck KGaA and gave the company a neutral rating in a research report on Friday, August 4th. Commerzbank Ag set a €109.00 ($129.76) price objective on Merck KGaA and gave the company a neutral rating in a research report on Wednesday, August 9th. Berenberg Bank set a €109.00 ($129.76) price objective on Merck KGaA and gave the company a neutral rating in a research report on Friday, August 18th. Finally, DZ Bank AG reiterated a neutral rating on shares of Merck KGaA in a research report on Monday, May 29th. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Merck KGaA presently has an average rating of Hold and a consensus price target of €108.38 ($129.02).

Merck KGaA (FRA:MRK) traded up 0.19% during mid-day trading on Thursday, reaching €96.51. 315 shares of the company’s stock were exchanged. The stock has a market cap of €41.96 billion and a price-to-earnings ratio of 25.16. The stock has a 50-day moving average of €93.46 and a 200-day moving average of €102.32. Merck KGaA has a one year low of €89.00 and a one year high of €115.00.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2017/09/22/merck-kgaa-mrk-given-a-119-00-price-target-by-kepler-capital-markets-analysts.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.